Table 3. Clinical and laboratory data of 4 adults with undifferentiated fever and a single convalescent-phase titer to Neotoma albigula–derived Bartonella antigens*.
| Patient no., age (y), sex | DOI | T (°C)† | Leukocyte × 103/μL‡ | PLT × 103/μL‡ | HCT (%)† | AST (U/L)† | BIL (mg/dL)† | LDH (U/L)† | Doubling dilution end titer (convalescent phase)§ |
||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bartonella from Neotoma | B. vinsonii from Microtus pennsylvanicus | B. quintana | B. henselae | B. elizabethae | |||||||||
| 6, 42, M | 2 | 39.1 | 23.3 | 11 | 47 | 4,580 | 4.3 | 16,000 | 2,048 | 64 | <32 | <64 | 128 |
| 7, 17, M | 3 | 38.8 | 3.3 | 108 | 43 | 60 | 1.4 | 229 | 1,024 | 256 | 256 | 64 | 512 |
| 8, 23, F | 3 | 39.0 | 3.9 | 245 | 44 | 834 | 5.2 | NA | 512 | 256 | 256 | 64 | 64 |
| 9, 32, M | 7 | 39.0 | 2.9 | 35 | 44 | 1,049 | 3.8 | 1,248 | 512 | NA | NA | NA | NA |
*DOI, day of symptomatic illness at hospitalization; T, temperature; PLT, platelet count; HCT, hematocrit; AST, aspartate aminotransferase; BIL, bilirubin; LDH, lactate dehydrogenase; NA, not available. †Highest value during 2–6 d of hospitalization. ‡Minimum value. §Convalescent-phase titers 2–6 wk after hospital admission.